83 related articles for article (PubMed ID: 15591800)
1. Increased alpha 7 nicotinic acetylcholine receptor protein levels in Alzheimer's disease patients.
Chu LW; Ma ES; Lam KK; Chan MF; Lee DH
Dement Geriatr Cogn Disord; 2005; 19(2-3):106-12. PubMed ID: 15591800
[TBL] [Abstract][Full Text] [Related]
2. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
Schrijnemaekers AM; de Jager CA; Hogervorst E; Budge MM
J Clin Exp Neuropsychol; 2006 Apr; 28(3):438-55. PubMed ID: 16618630
[TBL] [Abstract][Full Text] [Related]
3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
4. [CSF levels of total tau protein in patients with mild cognitive impairment and Alzheimer's disease].
Kaiser E; Schönknecht P; Hunt A; Thomann PA; Pantel J; Schröder J
Z Gerontol Geriatr; 2008 Dec; 41(6):497-501. PubMed ID: 18327693
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease.
Kim KW; Lee DY; Jhoo JH; Youn JC; Suh YJ; Jun YH; Seo EH; Woo JI
Dement Geriatr Cogn Disord; 2005; 19(5-6):324-30. PubMed ID: 15785033
[TBL] [Abstract][Full Text] [Related]
6. CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease.
Chiasserini D; Parnetti L; Andreasson U; Zetterberg H; Giannandrea D; Calabresi P; Blennow K
J Alzheimers Dis; 2010; 22(4):1281-8. PubMed ID: 20930282
[TBL] [Abstract][Full Text] [Related]
7. How to calculate an MMSE score from a MODA score (and vice versa) in patients with Alzheimer's disease.
Cazzaniga R; Francescani A; Saetti C; Spinnler H
Neurol Sci; 2003 Nov; 24(4):261-7. PubMed ID: 14658044
[TBL] [Abstract][Full Text] [Related]
8. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.
Güntert A; Campbell J; Saleem M; O'Brien DP; Thompson AJ; Byers HL; Ward MA; Lovestone S
J Alzheimers Dis; 2010; 21(2):585-96. PubMed ID: 20571216
[TBL] [Abstract][Full Text] [Related]
9. An adaptation of the modified mini-mental state examination: analysis of demographic influences and normative data: the cache county study.
Tschanz JT; Welsh-Bohmer KA; Plassman BL; Norton MC; Wyse BW; Breitner JC;
Neuropsychiatry Neuropsychol Behav Neurol; 2002 Mar; 15(1):28-38. PubMed ID: 11877549
[TBL] [Abstract][Full Text] [Related]
10. Smell identification test as an indicator for cognitive impairment in Alzheimer's disease.
Suzuki Y; Yamamoto S; Umegaki H; Onishi J; Mogi N; Fujishiro H; Iguchi A
Int J Geriatr Psychiatry; 2004 Aug; 19(8):727-33. PubMed ID: 15290695
[TBL] [Abstract][Full Text] [Related]
11. Does the combination of the MMSE and clock drawing test (mini-clock) improve the detection of mild Alzheimer's disease and mild cognitive impairment?
Cacho J; Benito-León J; García-García R; Fernández-Calvo B; Vicente-Villardón JL; Mitchell AJ
J Alzheimers Dis; 2010; 22(3):889-96. PubMed ID: 20858951
[TBL] [Abstract][Full Text] [Related]
12. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease.
Ala TA; Hughes LF; Kyrouac GA; Ghobrial MW; Elble RJ
Int J Geriatr Psychiatry; 2002 Jun; 17(6):503-9. PubMed ID: 12112173
[TBL] [Abstract][Full Text] [Related]
13. [Validation of a short test (3MS-R) for detecting Alzheimer's disease].
Alexopoulos P; Nadler K; Cramer B; Herpertz SC; Kurz A
Fortschr Neurol Psychiatr; 2007 Dec; 75(12):728-36. PubMed ID: 17607642
[TBL] [Abstract][Full Text] [Related]
14. Urinary homocysteic acid levels correlate with mini-mental state examination scores in Alzheimer's disease patients.
Hasegawa T; Ichiba M; Matsumoto SE; Kasanuki K; Hatano T; Fujishiro H; Iseki E; Hattori N; Yamada T; Tabira T
J Alzheimers Dis; 2012; 31(1):59-64. PubMed ID: 22531414
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease.
Liang F; Jia J; Wang S; Qin W; Liu G
J Clin Neurosci; 2013 Mar; 20(3):357-61. PubMed ID: 23228658
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Telephone Interview for Cognitive Status (TICS) in Japanese.
Konagaya Y; Washimi Y; Hattori H; Takeda A; Watanabe T; Ohta T
Int J Geriatr Psychiatry; 2007 Jul; 22(7):695-700. PubMed ID: 17431929
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease.
Kuyumcu ME; Yesil Y; Oztürk ZA; Kizilarslanoğlu C; Etgül S; Halil M; Ulger Z; Cankurtaran M; Arıoğul S
Dement Geriatr Cogn Disord; 2012; 34(2):69-74. PubMed ID: 22922667
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
[TBL] [Abstract][Full Text] [Related]
20. Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population.
Li GY; Watanabe I; Kunitake Y; Sugataka K; Muraoka T; Kojima N; Kawashima T; Yamada S
Psychiatry Clin Neurosci; 2008 Oct; 62(5):562-7. PubMed ID: 18950376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
